{
  "DOI": "10.1007/s10689-018-00118-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-00118-0",
  "alternative-id": [
    "118"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "3 January 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The Medical Research Ethical Committee concluded that the Medical Research Human Subject Acts (WMO) does not apply."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-3181-5942",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Bakhuizen",
      "given": "J. J.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Hogervorst",
      "given": "F. B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Velthuizen",
      "given": "M. E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ruijs",
      "given": "M. W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Engelen",
      "given": "K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Os",
      "given": "T. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gille",
      "given": "J. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Collée",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van den Ouweland",
      "given": "A. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Asperen",
      "given": "C. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kets",
      "given": "C. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mensenkamp",
      "given": "A. R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Leter",
      "given": "E. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Blok",
      "given": "M. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Jong",
      "given": "M. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ausems",
      "given": "M. G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        1,
        3
      ]
    ],
    "date-time": "2019-01-03T05:38:49Z",
    "timestamp": 1546493929000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        11,
        21
      ]
    ],
    "date-time": "2020-11-21T12:36:44Z",
    "timestamp": 1605962204000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        9
      ]
    ],
    "date-time": "2023-10-09T12:25:56Z",
    "timestamp": 1696854356763
  },
  "is-referenced-by-count": 17,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        1,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            1,
            3
          ]
        ],
        "date-time": "2019-01-03T00:00:00Z",
        "timestamp": 1546473600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00118-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-00118-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00118-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "273-280",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        1,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        1,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "118_CR1",
      "unstructured": "Netherlands Comprehensive Cancer Organisation (IKNL) (2016) Dutch cancer Figs. 2016 [Internet]. http://www.cijfersoverkanker.nl/ . Accessed May 21 2018"
    },
    {
      "DOI": "10.1146/annurev.genom.9.081307.164339",
      "author": "C Turnbull",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "118_CR2",
      "unstructured": "Turnbull C, Rahman N (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9:321–345",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2015.65.0747",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "1460",
      "issue": "13",
      "journal-title": "J Clin Oncol",
      "key": "118_CR3",
      "unstructured": "Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34(13):1460–1468",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1093/oxfordjournals.aje.a115616",
      "author": "EB Claus",
      "doi-asserted-by": "publisher",
      "first-page": "961",
      "issue": "6",
      "journal-title": "Am J Epidemiol",
      "key": "118_CR4",
      "unstructured": "Claus EB, Risch NJ, Thompson D (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131(6):961–972",
      "volume": "131",
      "year": "1990"
    },
    {
      "key": "118_CR5",
      "unstructured": "NABON (2017) Breast Cancer, Dutch Guideline [Internet]. http://www.oncoline.nl/borstkanker . Accessed May 25 2018"
    },
    {
      "key": "118_CR6",
      "unstructured": "National Comprehensive Cancer Network (2018) NCCN Clinical Practice Guidelines in Oncology: genetic/familial high risk assessment: breast and ovarian (Version 2.2019) [internet]. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf (registration required). Accessed 7 Nov 2018"
    },
    {
      "author": "MA Adank",
      "first-page": "A8910",
      "journal-title": "Ned Tijdschr Geneeskd",
      "key": "118_CR7",
      "unstructured": "Adank MA, Hes FJ, van Zelst-Stams WAG et al (2015) CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer (in Dutch). Ned Tijdschr Geneeskd 159:A8910",
      "volume": "159",
      "year": "2015"
    },
    {
      "author": "K Schneider",
      "key": "118_CR8",
      "unstructured": "Schneider K, Zelley K, Nichols KE et al (1999) Li–Fraumeni syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al (eds) GeneReviews [Internet]. University of Washington, Seattle, WA",
      "volume-title": "GeneReviews [Internet]",
      "year": "1999"
    },
    {
      "DOI": "10.1200/JCO.2008.16.6959",
      "author": "KD Gonzalez",
      "doi-asserted-by": "publisher",
      "first-page": "1250",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "118_CR9",
      "unstructured": "Gonzalez KD, Noltner KA, Buzin CH et al (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250–1256",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.30248",
      "author": "PL Mai",
      "doi-asserted-by": "publisher",
      "first-page": "3673",
      "issue": "23",
      "journal-title": "Cancer",
      "key": "118_CR10",
      "unstructured": "Mai PL, Best AF, Peters JA et al (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li–Fraumeni syndrome cohort. Cancer 122(23):3673–3681",
      "volume": "122",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "publisher",
      "first-page": "2345",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "118_CR11",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li–Fraumeni Syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352",
      "volume": "33",
      "year": "2015"
    },
    {
      "author": "FP Li",
      "first-page": "5358",
      "issue": "18",
      "journal-title": "Cancer Res",
      "key": "118_CR12",
      "unstructured": "Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358–5362",
      "volume": "48",
      "year": "1988"
    },
    {
      "author": "JM Birch",
      "first-page": "1298",
      "issue": "5",
      "journal-title": "Cancer Res",
      "key": "118_CR13",
      "unstructured": "Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the P53 gene among 21 Li–Fraumeni families. Cancer Res 54(5):1298–1304",
      "volume": "54",
      "year": "1994"
    },
    {
      "author": "RA Eeles",
      "first-page": "101",
      "journal-title": "Cancer Surv",
      "key": "118_CR14",
      "unstructured": "Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:101–124",
      "volume": "25",
      "year": "1995"
    },
    {
      "DOI": "10.1136/jmg.38.1.43",
      "author": "A Chompret",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "issue": "1",
      "journal-title": "J Med Genet",
      "key": "118_CR15",
      "unstructured": "Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38(1):43–47",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7967",
      "author": "J Tinat",
      "doi-asserted-by": "publisher",
      "first-page": "e108-9",
      "issue": "26",
      "journal-title": "J Clin Oncol",
      "key": "118_CR16",
      "unstructured": "Tinat J, Bougeard G, Baert-Desurmont S et al (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27(26):e108-9",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104976",
      "author": "M Renaux-Petel",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "issue": "3",
      "journal-title": "J Med Genet",
      "key": "118_CR17",
      "unstructured": "Renaux-Petel M, Charbonnier F, Thery JC et al (2018) Contribution of de novo and mosaic TP53 mutations to Li–Fraumeni syndrome. J Med Genet 55(3):173–180",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1093/jnci/djy001",
      "author": "HQ Rana",
      "doi-asserted-by": "publisher",
      "first-page": "863",
      "issue": "8",
      "journal-title": "J Natl Cancer Inst",
      "key": "118_CR18",
      "unstructured": "Rana HQ, Gelman R, LaDuca H et al (2018) Differences in TP53 mutation carrier phenotypes emerge from panel-based testing. J Natl Cancer Inst 110(8):863–870",
      "volume": "110",
      "year": "2018"
    },
    {
      "DOI": "10.1097/CCO.0000000000000423",
      "author": "A Amadou",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "issue": "1",
      "journal-title": "Curr Opin Oncol",
      "key": "118_CR19",
      "unstructured": "Amadou A, Waddington Achatz MI, Hainaut P (2018) Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li–Fraumeni syndrome. Curr Opin Oncol 30(1):23–29",
      "volume": "30",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.23656",
      "author": "C Fortuno",
      "doi-asserted-by": "publisher",
      "first-page": "1764",
      "journal-title": "Hum Mutat",
      "key": "118_CR20",
      "unstructured": "Fortuno C, James PA, Spurdle AB (2018) Current review of TP53 pathogenic germline variants in breast cancer patients outside Li–Fraumeni syndrome. Hum Mutat 39:1764–1773",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.23035",
      "author": "L Bouaoun",
      "doi-asserted-by": "publisher",
      "first-page": "865",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "118_CR21",
      "unstructured": "Bouaoun L, Sonkin D, Ardin M et al (2016) TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat 37(9):865–876",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejca.2005.11.032",
      "author": "F Lalloo",
      "doi-asserted-by": "publisher",
      "first-page": "1143",
      "issue": "8",
      "journal-title": "Eur J Cancer",
      "key": "118_CR22",
      "unstructured": "Lalloo F, Varley J, Moran A et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42(8):1143–1150",
      "volume": "42",
      "year": "2006"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-0851",
      "author": "J Mouchawar",
      "doi-asserted-by": "publisher",
      "first-page": "4795",
      "issue": "12",
      "journal-title": "Cancer Res",
      "key": "118_CR23",
      "unstructured": "Mouchawar J, Korch C, Byers T et al (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res 70(12):4795–4800",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-012-9557-z",
      "author": "JM McCuaig",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "118_CR24",
      "unstructured": "McCuaig JM, Armel SR, Novokmet A et al (2012) Routine TP53 testing for breast cancer under age 30: ready for prime time? Fam Cancer 11(4):607–613",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-009-9287-z",
      "author": "OM Ginsburg",
      "doi-asserted-by": "publisher",
      "first-page": "563",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "118_CR25",
      "unstructured": "Ginsburg OM, Akbari MR, Aziz Z et al (2009) The prevalence of germline TP53 mutations in women diagnosed with breast cancer before age 30. Fam Cancer 8(4):563–567",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1093/annonc/mdv592",
      "author": "DM Eccles",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "3",
      "journal-title": "Ann Oncol",
      "key": "118_CR26",
      "unstructured": "Eccles DM, Li N, Handwerker R et al (2016) Genetic testing in a cohort of young patients with HER2-amplified breast cancer. Ann Oncol 27(3):467–473",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmg.2010.078113",
      "author": "JR Wilson",
      "doi-asserted-by": "publisher",
      "first-page": "771",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "118_CR27",
      "unstructured": "Wilson JR, Bateman AC, Hanson H et al (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47(11):771–774",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-012-1993-9",
      "author": "S Masciari",
      "doi-asserted-by": "publisher",
      "first-page": "1125",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "118_CR28",
      "unstructured": "Masciari S, Dillon DA, Rath M et al (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li–Fraumeni syndrome consortium effort. Breast Cancer Res Treat 133(3):1125–1130",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cncr.26377",
      "author": "A Melhem-Bertrandt",
      "doi-asserted-by": "publisher",
      "first-page": "908",
      "issue": "4",
      "journal-title": "Cancer",
      "key": "118_CR29",
      "unstructured": "Melhem-Bertrandt A, Bojadzieva J, Ready KJ et al (2012) Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908–913",
      "volume": "118",
      "year": "2012"
    },
    {
      "key": "118_CR30",
      "unstructured": "Netherlands Foundation for the Detection of Hereditary Tumours (STOET) and the Dutch Society of Clinical Genetics (VKGN) (2005) Guidelines for the diagnosis and prevention of hereditary cancer predisposition syndromes (in Dutch). Edition 2005"
    },
    {
      "key": "118_CR31",
      "unstructured": "Netherlands Foundation for the Detection of Hereditary Tumours (STOET) and the Dutch Society of Clinical Genetics (VKGN) (2010) Guidelines for the diagnosis and prevention of hereditary cancer predisposition syndromes (in Dutch). Edition 2010"
    },
    {
      "key": "118_CR32",
      "unstructured": "Netherlands Foundation for the Detection of Hereditary Tumours (STOET) and the Dutch Society of Clinical Genetics (VKGN) (2017) Guidelines for the diagnosis and prevention of hereditary cancer predisposition syndromes (in Dutch). Edition 2017"
    },
    {
      "DOI": "10.1007/s10689-018-0103-5",
      "author": "JJ Bakhuizen",
      "doi-asserted-by": "publisher",
      "journal-title": "Fam Cancer",
      "key": "118_CR33",
      "unstructured": "Bakhuizen JJ, Velthuizen ME, Stehouwer S et al (2018) Genetic counselling of young women with breast cancer for Li–Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals. Fam Cancer. https://doi.org/10.1007/s10689-018-0103-5",
      "year": "2018"
    },
    {
      "DOI": "10.1038/bjc.2013.805",
      "author": "MR Wevers",
      "doi-asserted-by": "publisher",
      "first-page": "1081",
      "issue": "4",
      "journal-title": "Br J Cancer",
      "key": "118_CR34",
      "unstructured": "Wevers MR, Aaronson NK, Verhoef S et al (2014) Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. Br J Cancer 110(4):1081–1087",
      "volume": "110",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "118_CR35",
      "unstructured": "Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1186/bcr3172",
      "author": "DS Lee",
      "doi-asserted-by": "publisher",
      "first-page": "R66",
      "issue": "2",
      "journal-title": "Breast Cancer Res",
      "key": "118_CR36",
      "unstructured": "Lee DS, Yoon SY, Looi LM et al (2012) Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res 14(2):R66. https://doi.org/10.1186/bcr3172",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1399-0004.2008.01133.x",
      "author": "P Ang",
      "doi-asserted-by": "publisher",
      "first-page": "294",
      "issue": "3",
      "journal-title": "Clin Genet",
      "key": "118_CR37",
      "unstructured": "Ang P, Lim IH, Yong RY, Lee AS (2009) A molecular approach for identifying individuals with Li–Fraumeni syndrome who have a limited family history. Clin Genet 75(3):294–297",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0057581",
      "author": "DM Carraro",
      "doi-asserted-by": "publisher",
      "first-page": "e57581",
      "issue": "3",
      "journal-title": "PLoS ONE",
      "key": "118_CR38",
      "unstructured": "Carraro DM, Koike Folgueira MA, Garcia Lisboa BC et al (2013) Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS ONE 8(3):e57581",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-012-2375-z",
      "author": "MG Rath",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "118_CR39",
      "unstructured": "Rath MG, Masciari S, Gelman R et al (2013) Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat 139(1):193–198",
      "volume": "139",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10689-017-0002-1",
      "author": "R O’Shea",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "issue": "1",
      "journal-title": "Fam Cancer",
      "key": "118_CR40",
      "unstructured": "O’Shea R, Clarke R, Berkley E et al (2017) Next generation sequencing is informing phenotype: a TP53 example. Fam Cancer 17(1):123–128",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-017-4531-y",
      "author": "K Schon",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "118_CR41",
      "unstructured": "Schon K, Tischkowitz M (2018) Clinical implications of germline mutations in breast cancer: TP53. Breast Cancer Res Treat 167(2):417–423",
      "volume": "167",
      "year": "2018"
    },
    {
      "DOI": "10.1186/1748-717X-5-104",
      "author": "S Heymann",
      "doi-asserted-by": "publisher",
      "first-page": "104",
      "journal-title": "Radiat Oncol",
      "key": "118_CR42",
      "unstructured": "Heymann S, Delaloge S, Rahal A et al (2010) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li–Fraumeni syndrome. Radiat Oncol 5:104",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-009-9265-5",
      "author": "C Lammens",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "118_CR43",
      "unstructured": "Lammens C, Bleiker E, Aaronson N et al (2009) Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Fam Cancer 8(4):457–464",
      "volume": "8",
      "year": "2009"
    },
    {
      "key": "118_CR44",
      "unstructured": "PGD Netherlands (2017) Annual report 2017 [Internet]. https://www.pgdnederland.nl/en/annual-reports . Accessed 7 Nov 2018"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.1968",
      "author": "ML Ballinger",
      "doi-asserted-by": "publisher",
      "first-page": "1634",
      "issue": "12",
      "journal-title": "JAMA Oncol",
      "key": "118_CR45",
      "unstructured": "Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li–Fraumeni Syndrome using whole-body magnetic sesonance imaging: a meta-analysis. JAMA Oncol 3(12):1634–1639",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1470-2045(11)70119-X",
      "author": "A Villani",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "118_CR46",
      "unstructured": "Villani A, Tabori U, Schiffman J et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: a prospective observational study. Lancet Oncol 12(6):559–567",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S1470-2045(16)30249-2",
      "author": "A Villani",
      "doi-asserted-by": "publisher",
      "first-page": "1295",
      "issue": "9",
      "journal-title": "Lancet Oncol",
      "key": "118_CR47",
      "unstructured": "Villani A, Shore A, Wasserman JD et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17(9):1295–1305",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nrclinonc.2014.41",
      "author": "KA McBride",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "issue": "5",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "118_CR48",
      "unstructured": "McBride KA, Ballinger ML, Killick E et al (2014) Li–Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol 11(5):260–271",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.1346",
      "author": "MWG Ruijs",
      "doi-asserted-by": "publisher",
      "first-page": "1733",
      "issue": "12",
      "journal-title": "JAMA Oncol",
      "key": "118_CR49",
      "unstructured": "Ruijs MWG, Loo CE, van Buchem CAJM, Bleiker EMA, Sonke GS (2017) Surveillance of Dutch patients with Li–Fraumeni syndrome: the LiFe-Guard Study. JAMA Oncol 3(12):1733–1734",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1002/pon.1352",
      "author": "SK Peterson",
      "doi-asserted-by": "publisher",
      "first-page": "783",
      "issue": "8",
      "journal-title": "Psychooncology",
      "key": "118_CR50",
      "unstructured": "Peterson SK, Pentz RD, Marani SK et al (2008) Psychological functioning in persons considering genetic counseling and testing for Li–Fraumeni syndrome. Psychooncology 17(8):783–789",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2009.27.2112",
      "author": "CR Lammens",
      "doi-asserted-by": "publisher",
      "first-page": "3008",
      "issue": "18",
      "journal-title": "J Clin Oncol",
      "key": "118_CR51",
      "unstructured": "Lammens CR, Aaronson NK, Wagner A et al (2010) Genetic testing in Li–Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol 28(18):3008–3014",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1002/pon.1951",
      "author": "CR Lammens",
      "doi-asserted-by": "publisher",
      "first-page": "631",
      "issue": "6",
      "journal-title": "Psychooncology",
      "key": "118_CR52",
      "unstructured": "Lammens CR, Bleiker EM, Verhoef S et al (2011) Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes. Psychooncology 20(6):631–638",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10689-017-0020-z",
      "author": "J Azzollini",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "3",
      "journal-title": "Fam Cancer",
      "key": "118_CR53",
      "unstructured": "Azzollini J, Mariani M, Peissel B, Manoukian S (2018) Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations. Fam Cancer 17(3):317–319",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2017.250",
      "author": "SP MacFarland",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "118_CR54",
      "unstructured": "MacFarland SP, Maxwell KN (2018) The differential diagnosis of a TP53 genetic testing result. Genet Med 20(8):806–808",
      "volume": "20",
      "year": "2018"
    }
  ],
  "reference-count": 54,
  "references-count": 54,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-00118-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}